Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Celularity (CELU) Revenue (2020 - 2025)

Celularity (CELU) has disclosed Revenue for 6 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • For Q4 2025, Revenue rose 496.51% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $26.6 million, down 27.81%, while the annual FY2025 figure was $26.6 million, 51.03% down from the prior year.
  • Revenue hit $4.1 million in Q4 2025 for Celularity, down from $5.3 million in the prior quarter.
  • Across five years, Revenue topped out at $14.7 million in Q1 2024 and bottomed at $688000.0 in Q4 2024.
  • Average Revenue over 5 years is $6.3 million, with a median of $4.5 million recorded in 2021.
  • Year-over-year, Revenue plummeted 94.32% in 2024 and then skyrocketed 496.51% in 2025.
  • Celularity's Revenue stood at $4.9 million in 2021, then decreased by 14.97% to $4.1 million in 2022, then skyrocketed by 193.34% to $12.1 million in 2023, then tumbled by 94.32% to $688000.0 in 2024, then surged by 496.51% to $4.1 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $4.1 million, $5.3 million, and $5.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.